Effects of granulocyte-colony stimulating factor and the expression of its receptor on various malignant cells

Korean Journal of Hematology

Volumn 47, Issue 3, 2012, Pages 219-224

  Moon, Hee Won ^a   Kim, Tae Young ^b   Oh, Bo Ra ^b   Hwang, Sang Mee ^b   Kwon, Jiseok ^b   Ku, Ja Lok ^b   Lee, Dong Soon ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

AML; Differentiation; G CSF; Proliferation; Solid tumor

Indexed keywords

CD11B ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BREAST CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATOBLASTOMA; LARYNX SQUAMOUS CELL CARCINOMA; LEUKEMIA CELL LINE; MELANOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84874023759     PISSN: 17387949     EISSN: 20929129     Source Type: Journal    
DOI: 10.5045/kjh.2012.47.3.219     Document Type: Article

References (30)

1. Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Eur J Haematol 2004;72: 89-106.
2. Moon HW, Shin S, Kim HY, et al. Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia. Leukemia 2006;20: 1408-13.
3. Sung L, Nathan PC, Alibhai SM, Tomlinson GA, Beyene J. Meta-analysis: effect of prophylactic hematopoietic colonystimulating factors on mortality and outcomes of infection. Ann Intern Med 2007;147: 400-11.
4. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78: 2791-808.
5. Shimizu K, Kitabayashi I, Kamada N, et al. AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/ enhancer binding protein epsilon. Blood 2000;96: 288-96.
6. Hirbe AC, Uluckan O, Morgan EA, et al. Granulocyte colonystimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood 2007;109: 3424-31.
7. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994;56: 853-7.
8. Natori T, Sata M, Washida M, Hirata Y, Nagai R, Makuuchi M. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun 2002;297: 1058-61.
9. Noda I, Fujieda S, Ohtsubo T, et al. Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neckcarcinoma cell lines. Int J Cancer 1999;80: 78-84.
10. Obermueller E, Vosseler S, Fusenig NE, Mueller MM. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 2004;64: 7801-12.
11. Savarese TM, Mitchell K, McQuain C, et al. Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett 2001;162: 105-15.
12. Yang X, Liu F, Xu Z, et al. Expression of granulocyte colony stimulating factor receptor in human colorectal cancer. Postgrad Med J 2005;81: 333-7.
13. Morales-Arias J, Meyers PA, Bolontrade MF, et al. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration. Cancer 2007;110: 1568-77.
14. Park HB, Yang JH, Chung KH. Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells. Korean J Hematol 2011;46: 265-73.
15. Ohno R, Tomonaga M, Kobayashi T, et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 1990;323: 871-7.
16. Heil G, Hoelzer D, Sanz MA, et al. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. Blood 1997;90: 4710-8.
17. Godwin JE, Kopecky KJ, Head DR, et al. A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031). Blood 1998;91: 3607-15.
18. Usuki K, Urabe A, Masaoka T, et al. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study. Br J Haematol 2002;116: 103-12.
19. Kroger N, Sonnenberg S, Cortes-Dericks L, Freiberger P, Mollnau H, Zander AR. Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study. Transfusion 2004;44: 104-10.
20. Hernandez-Bernal F, Garcia-García I, Gonzalez-Delgado CA, et al. Bioequivalence of two recombinant granulocyte colony stimulating factor formulations in healthy male volunteers. Biopharm Drug Dispos 2005;26: 151-9.
21. Camera A, Volpicelli M, Villa MR, Risitano AM, Rossi M, Rotoli B. Complete remission induced by high dose erythropoietin and granulocyte colony stimulating factor in acute erythroleukemia (AML-M6 with maturation). Haematologica 2002;87: 1225-7.
22. Da Silva N, Meyer-Monard S, Menot ML, et al. Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO. Hematol J 2000;1: 316-28.
23. Ferrara F, Di Noto R, Viola A, et al. Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation. Br J Haematol 1999;106: 520-3.
24. Nimubona S, Grulois I, Bernard M, et al. Complete remission in hypoplastic acute myeloid leukemia induced by G-CSF without chemotherapy: report on three cases. Leukemia 2002;16: 1871-3.
25. Takamatsu Y, Miyamoto T, Iwasaki H, Makino S, Tamura K. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature. Acta Haematol 1998;99: 224-30.
26. Hernandez-Campo PM, Almeida J, Matarraz S, de Santiago M, Sanchez ML, Orfao A. Quantitative analysis of the expression of glycosylphosphatidylinositol-anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrow. Cytometry B Clin Cytom 2007;72: 34-42.
27. van Lochem EG, van der Velden VH, Wind HK, et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin Cytom 2004;60: 1-13.
28. Ichiishi E, Yoshikawa T, Kogawa T, Yoshida N, Kondo M. Possible paracrine growth of adenocarcinoma of the stomach induced by granulocyte colony stimulating factor produced by squamous cell carcinoma of the oesophagus. Gut 2000;46: 432-4.
29. Horii A, Shimamura K, Honjo Y, et al. Granulocyte colony stimulating factor-producing tongue carcinoma. Head Neck 1997;19: 351-6.
30. Tachibana M, Miyakawa A, Nakashima J, et al. Autocrine growth promotion by multiple hematopoietic growth factors in the established renal cell carcinoma line KU-19-20. Cell Tissue Res 2000;301: 353-67.